Reliability and Validity of a Danish Version of the Multiple Sclerosis Neuropsychological Screening Questionnaire
Authors: Sejbæk Tobias , Blaabjerg Morten , Sprogøe Pippi , Ravnborg Mads 
Published: February 2018

CME/CNE Information

Activity Available Online:

To access the article, post-test, and evaluation online, go to http://www.cmscscholar.org.

Target Audience:

The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS).

Learning Objectives:

Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit

The CMSC designates this journal-based activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Credit

The CMSC designates this enduring material for .75 contact hours.

Disclosures:

Editor in Chief of the International Journal of MS Care (IJMSC), has served as Physician Planner for this activity. He has received royalties from Springer Publishing; has received consulting fees from Ipsen; and has performed contracted research for Biogen, Adamas Pharmaceuticals, and Acorda Therapeutics.Francois Bethoux, MD,

has served as reviewer for this activity. She has disclosed no relevant financial relationships.Laurie Scudder, DNP, NP,

has received honoraria from lectures at a Biogen symposium; has performed contracted research as principal investigator of a phase 4 trial with support from Biogen; has served on the scientific advisory boards of Novartis, Biogen, Teva, Merck, and Roche; and has received travel funding or speaker honoraria from Biogen, Teva, and Novartis.Tobias Sejbæk, MD,

has received honoraria from lectures at a symposium organized by Biogen Denmark.Morten Blaabjerg, MD, PhD,

has disclosed no relevant financial relationships.Pippi Sprogøe, MSc,

has performed contracted research as principal investigator of phase 3 and 4 studies by Biogen, Roche, Novartis, and Genzyme.Mads Ravnborg, MD, DMsc,

The peer reviewers for the IJMSC have disclosed no relevant financial relationships.

The staff at the IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships.

Note: Disclosures listed for authors are those applicable at the time of their work on this project and within the previous 12 months.

Method of Participation:

Release Date: February 1, 2018

Valid for Credit Through: February 1, 2019

In order to receive CME/CNE credit, participants must:

Statements of Credit are awarded upon successful completion of the post-test with a passing score of &gt;70% and the evaluation.

There is no fee to participate in this activity.

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.